Vanda Pharmaceuticals Inc. (VNDA)

Typically moves ±7.89% on earnings

EARNINGS ANALYTICS

event_upcoming Est. Next Earnings: 2026-10-14 ESTIMATED

Across 22 earnings reports since May 05, 2021, Vanda Pharmaceuticals Inc. (VNDA) has a clear post-earnings pattern. It moves ±7.89% on average after reporting and finishes higher 27.3% of the time. Its largest post-earnings gain was +11.81% (Feb 07, 2024) and its largest decline was -21.94% (Nov 08, 2023). The next earnings report is predicted for 2026-10-14 (estimated).

Earnings reactions

How VNDA moved on each past earnings report.

Up Down

Earnings Impact

Total Earnings

Avg Abs. Movement

±7.89%

Positive %

27.3%

Negative %

72.7%

Historical Earnings Statistics

Date	Timing	Earnings move	SEC Filing
Aug 05, 2026	☽ POST	+1.49%	open_in_new
May 06, 2026	☽ POST	-13.95%	open_in_new
Feb 11, 2026	☽ POST	-17.63%	open_in_new
Oct 29, 2025	☽ POST	-20.15%	open_in_new
Jul 31, 2025	☀ PRE	-8.78%	open_in_new
May 07, 2025	☽ POST	-3.65%	open_in_new
Feb 13, 2025	☽ POST	-5.96%	open_in_new
Nov 06, 2024	☽ POST	+2.66%	open_in_new
Jul 31, 2024	☽ POST	-3.42%	open_in_new
May 08, 2024	☽ POST	-6.53%	open_in_new
Feb 07, 2024	☽ POST	+11.81%	open_in_new
Nov 08, 2023	☽ POST	-21.94%	open_in_new
Jul 27, 2023	☽ POST	-8.05%	open_in_new
May 03, 2023	☽ POST	+7.51%	open_in_new
Feb 08, 2023	☽ POST	+0.84%	open_in_new
Nov 02, 2022	☽ POST	-1.75%	open_in_new
Aug 03, 2022	☽ POST	-4.63%	open_in_new
May 05, 2022	☽ POST	-2.04%	open_in_new
Feb 23, 2022	☽ POST	-2.6%	open_in_new
Nov 03, 2021	☽ POST	-14.05%	open_in_new
Jul 28, 2021	☽ POST	-8.5%	open_in_new
May 05, 2021	☽ POST	+5.61%	open_in_new

event

Earnings Count

Total earnings in dataset

trending_up

Avg Abs. Movement

±7.89%

Avg % price change on earnings

description

SEC Filings

View

Browse all SEC filings

account_balance

Institutional ownership

Holdings as of Jun 30, 2026 · SEC 13-F

View all 22 →

Funds holding

$96859576

Total value held

Buying

17 added · 5 reduced

Blackrock, Inc.

$46840870 +5.19%

State Street Corp

$21520399 +16.61%

Goldman Sachs Group Inc

$6341911 +23.62%

Federated Hermes, Inc.

$4371381 NEW BUY

Northern Trust Corp

$3675788 +33.18%

SEC Filing Types

Recent SEC Filings

10 most recent

Form	Date Filed	View on EDGAR
SCHEDULE 13G	20260819	open_in_new SEC.gov
SCHEDULE 13G	20260813	open_in_new SEC.gov
10-Q	20260806	open_in_new SEC.gov
8-K	20260805	open_in_new SEC.gov
3	20260608	open_in_new SEC.gov
4	20260608	open_in_new SEC.gov
4	20260608	open_in_new SEC.gov
4	20260608	open_in_new SEC.gov
4	20260608	open_in_new SEC.gov
4	20260608	open_in_new SEC.gov

Frequently asked about VNDA earnings

When does Vanda Pharmaceuticals Inc. report earnings next? expand_more

Vanda Pharmaceuticals Inc. (VNDA)'s next earnings date is estimated for 2026-10-14. This is a prediction based on its historical quarterly reporting pattern, not a company-confirmed date.

How much does VNDA stock move after earnings? expand_more

Over 22 reports, VNDA has moved an average of ±7.89% the session after earnings, closing higher 27.3% of the time.

What was VNDA's biggest post-earnings move? expand_more

VNDA's largest post-earnings gain on record was +11.81% on Feb 07, 2024, and its largest decline was -21.94% on Nov 08, 2023.

Where can I find Vanda Pharmaceuticals Inc.'s SEC filings? expand_more

All of Vanda Pharmaceuticals Inc.'s SEC filings — 10-K, 10-Q, 8-K and more — are listed in the SEC filings section on this page, each linking to the original document on SEC.gov.